CLINICAL_TRIALS
trial_result
· 2012-08-17
Clinical Trial Update: Imatinib in Systemic Sclerosis [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial of imatinib in systemic sclerosis completed with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Scleroderma, Systemic | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-08-17